对COVID-19患者的葡萄糖皮质类药物的分析,这些患者没有接受氧气治疗
Remo Daniel Covello1, Laura Pasin2, Stefano Fresilli3
1Busto Arsizio Hospital, Busto Arsizio, Lombardia, Italy.
NEJM evidence
|February 6, 2024
概括
葡萄糖皮质类药物可能会增加2019年冠状病毒病 (Covid-19) 的住院患者的死亡率,而这些患者不需要氧气. 这一发现表明,在非严重的Covid-19病例中使用这些类固醇时应谨慎.
科学领域:
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物用于严重的Covid-19,但可能会伤害不需要氧气的患者.
- 这项研究调查了在不依赖氧气的COVID-19患者中葡萄糖皮质体的死亡风险.
结论:
- 葡萄糖皮质类药物可能会增加住院的COVID-19患者的死亡率,而这些患者不需要氧气.
- 伤害27所需的数字表明存在相当大的风险.
- 研究结果表明,在这种患者群体中,应仔细考虑使用葡萄糖皮质类药物.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
251
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
251


